Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAPGEF4 | Q8WZA2 | 5/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7525261 | 0.78 | RAPGEF4 (0.39) | RAPGEF4KDM4EALDH1A1LMNAGAA | |
| SCHEMBL8388461 | 0.69 | ALDH1A1 (0.42) | RAPGEF4KDM4EALDH1A1LMNAGAA | |
| SCHEMBL22914917 | 0.69 | ALDH1A1 (0.42) | RAPGEF4KDM4EALDH1A1LMNAGAA | |
| SCHEMBL1227758 | 0.69 | RAPGEF4 (0.41) | RAPGEF4KDM4EALDH1A1LMNAGAA | |
| SCHEMBL27713988 | 0.67 | HTT (0.37) | RAPGEF4KDM4EALDH1A1LMNAGAA | |
| SCHEMBL2121908 | 0.67 | RAPGEF4 (0.39) | RAPGEF4KDM4EALDH1A1LMNAGAA | |
| SCHEMBL10994353 | 0.67 | RAPGEF4 (0.43) | RAPGEF4KDM4EALDH1A1LMNAGAA | |
| SCHEMBL28228647 | 0.67 | RAPGEF4 (0.39) | RAPGEF4KDM4EALDH1A1LMNAGAA | |
| SCHEMBL12597845 | 0.65 | L3MBTL1 (0.43) | RAPGEF4ALDH1A1LMNAMAPT | |
| SCHEMBL18535704 | 0.65 | ALDH1A1 (0.39) | RAPGEF4KDM4EALDH1A1LMNAGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7365198-B2 | Silyl compound, light emitting material, and organic light emitting device using the same | CANON KABUSHIKI KAISHA (JP) | 2008-04-29 | — | — | US | disclosed |
| US-20070205715-A1 | SILYL COMPOUND, LIGHT EMITTING MATERIAL, AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2007-09-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070205715-A1 | SILYL COMPOUND, LIGHT EMITTING MATERIAL, AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | LAS1L, CCNL2, EML4 | RAPGEF4 4457/4885KDM4E 1577/4885ALDH1A1 305/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.